Open AccessFINAL 36 MONTH RESULTS OF A MULTICENTER, RANDOMIZED TRIAL COMPARING THREE INDUCTION AGENTS (ALEMTUZUMAB, THYMOGLOBULIN AND BASILIXIMAB) WITH TACROLIMUS, MYCOPHENOLATE MOFETIL AND A RAPID STEROID WITHDRAWAL IN RENAL TRANSPLANTATION
Author(s) -
Michael J. Hanaway,
E. Steve Woodle,
Shamkant Mulgaonkar,
R Peddi,
G. Harrison,
K. Vandeputte,
William E. Fitzsimmons,
Roy First,
John Holman
Publication year - 2010
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-201007272-00037
Subject(s) - basiliximab , thymoglobulin , alemtuzumab , medicine , tacrolimus , mycophenolate , randomized controlled trial , transplantation , urology